Drug intelligence / Profile preview

TMEM175 inhibitor

Development stage
Unknown
Modality
Small Molecules
01

Overview

TMEM175 inhibitors are a class of small molecules designed to block the activity of transmembrane protein 175 (TMEM175), a structurally unique, constitutively active potassium and proton channel localized to the endolysosomal membrane. TMEM175 plays a critical role in maintaining lysosomal pH stability, membrane potential, and autophagic/mitophagic clearance. While TMEM175 loss-of-function mutations are strongly associated with an increased risk of Parkinson's disease, pharmacological inhibition of TMEM175 has been shown to paradoxically accelerate lysosomal macromolecular catabolism and macropinocytosis in certain contexts. Additionally, TMEM175 inhibition has demonstrated therapeutic potential in mitigating inflammatory responses and acute lung injury in macrophages by modulating the ROS-NF-κB signaling axis, and in reducing silica-induced cell death and inflammation.

Other names
TMEM175 inhibitorsTMEM-175 inhibitorsTMEM 175 inhibitorstransmembrane protein 175 inhibitortransmembrane protein 175 inhibitors
02

Targets

BCL-2 (BCL-2 family)TMEM175 (Transmembrane protein 175)

Beyond the preview

Go deeper on TMEM175 inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM175 inhibitor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call